Steven F Bolling Professor of Cardiac Surgery University of Michigan

Size: px
Start display at page:

Download "Steven F Bolling Professor of Cardiac Surgery University of Michigan"

Transcription

1 Optimal Treatment of Functional MR Steven F Bolling Professor of Cardiac Surgery University of Michigan

2 Functional MR

3 Functional MR in Ischemia Badhwar, Bolling, chapter in: Advances in Heart Failure, 2004

4 FMR : Ventricular Problem!! Badhwar, Bolling, chapter in: Advances in Heart Failure, 2004

5 Optimal Medical Therapy of FMR 1.0 : survival is not optimal! 0.8 surv vival MR grade No. None 9,405 Mild 2,062 Moderate 210 Severe Years Hickey et al: Circulation 78:1-51, 1988

6 In fact, even with small amounts of FMR it s terrible!! ERO RVol Grigioni et al: Circulation 103:1759, 2001

7 In 2012, with the modern testing & treatment they still do very badly! Szymanski et al Am J Cardiol 2011 Sep 21.

8 MR - Prognostic value 1300 CHF / FMR Mean age 67, mean EF 32% NYHA I 150 (15%) II 500 (49%) III 316 (31%) IV 57 (6%) Mean fu 2.7y Severe MR 24% Mild or Moderate MR 49% No MR 27% Rossi et al Heart 2011; 97:

9 More MR is worse! Ischemic or Dilated Rossi A et al. Heart 2011;97: by BMJ Publishing Group Ltd and British Cardiovascular Society

10 FMR Not just a late marker! FMR worsened odds ratio of death Rossi A et al. Heart 2011;97: by BMJ Publishing Group Ltd and British Cardiovascular Society

11 CRT for FMR : Less than half eligible, of which less than half respond van Bommel R J et al. Circulation 2011;124: Residual MR is still BAD!! Copyright American Heart Association

12 Undersized Mitral Repair for FMR Nyah, Nyah! Surgeons can fix FMR!!

13 Mitral Repair for FMR in CHF Bolling Chen Bishay Calafiore Buffolo Bitran Dreyfus Suma ACORN JTCVS pts Circ pts Eur JCTS pts Ann TS pts Ar Br Card pts J Card Surg pts JHLT pts JTCVS pts JTCVS pts 30 day mortality 1-5 %

14 Undersized Mitral Repair Feasible Low mortality Relief of MR Better Quality of life

15 Mitral Repair and CHF : benefit? Yikes - No mortality benefit!

16 Mitral Repair and CHF : benefit? Why - No mortality benefit?

17 FMR : residual / recurrent MR Progression of 3 or 4+ MR post-undersized annuloplasty (585) McGee, Gillinov et al, JTCVS, 2004;128:916-24

18 MVR and CHF Even a good operation, when done badly will not help a sick patient! recurrent FMR is still bad

19 Do a Better Operation : Surgical Predictors of Recurrent MR Flexible = 5x recurrent MR! Use rigid complete! Spoor, Geltz, Bolling : Circulation, 11/06

20

21 Flexible and/or partial bands don t provide a durable solution for FMR Magne et al. Cardiology 2009;112:

22 Strongest predictor of recurrent MR AP dia > 3.7 cm Recurrent MR Failed Repair AP diameter reduction!!! Kongsaerepong V et al. Am J Cardiol 2006;98:504-8

23 IMR-FMR ring designs Disproportionate AP dimension reduction Bothe W, Swanson J, et al., JTCVS 2010

24 MV repair 30 day mort 1.6% 1.6% Freedom from >1+ MR = 90%!! JTCVS 2006

25 FMR Surgery LV reverse remodeling

26 Braun J, et al., Leiden Ann Thorac Surg 2008;85:

27 FMR : Ventricular Problem!! LVEDD < 65 mm! Braun J, et al., Leiden Ann Thorac Surg 2008;85:

28 CHF Mitral Repair - Kron

29 CHF Mitral Repair - Hvass J Thorac Cardiovasc Surg Feb;139(2): The papillary muscle sling for ischemic mitral regurgitation.hvass U, Joudinaud T.

30 CorCap only

31 Randomized FMR trial JTCVS Fatouch 2009

32 FMR - survival

33 FMR exercise MR

34 Randomized CABG + MVr for mod IMR Mitral regurg volume - 69% vs 14% LV end systolic volumes - 24% vs 10% LV sphericity - 18% vs % Peak oxygen capacity vs 1.0 Brain natriuretic peptide - 76% vs 59% All p < 0.01! Mitral Valve Annuloplasty in Addition to Coronary Artery Bypass Grafting in Moderate Functional Ischemic Mitral Regurgitation Reverses Left Ventricular Remodelling and Restores Left Ventricular Geometry: Chan et al, CIRC March 2012

35 Functional MR Rigid, complete, undersized ring: Overall 6.5 year survival 86% DeBonis et al Eur J of CVTS, April 18, prospective propensity matched pts CHF / severe MR Editorial : SF Bolling : Mitral repair for functional mitral regurgitation in idiopathic dilated cardiomyopathy : A good operation done well may help!

36 Mitral Repair and IMR Repair vs. Just Replace it!

37 100 High Risk 100 Medium Risk I Worst 20%!! II 100 Low Risk Survival Replace Repair III - V Gillinov et al, JTCVS 2001;122:

38 Valve sparing replacement vs repair Survival for 4+ IMR Al Radi et al, Ann Thorac Surg, 2005;79:1260-7

39 Mt Sinai - High risk CABG/MVr

40 Severe Ischemic Mitral Regurgitation - repair vs replacement

41 Mitral Repair and IMR Good repair Replacement Bad repair

42 Catheter-Based Mitral Valve Repair MitraClip System

43 LV Volumes by MR Etiology Reduction in LV volumes, BUT CLIP LEAVES MR!! p< Baseline 12 Months p= Volume (ml) p= Volume (ml) p= LVEDV LVESV LVEDV LVESV Degen MR Subgroup n=88 0 FMR Device Subgroup n=30

44 Septal-Lateral Annular Dimension Baseline vs 12 Months, !! 6 End Systole End Diastole Dimension (cm) p= p= Baseline 12 Months Baseline 12 Month n=111 n=111 p-value compares baseline to 12 month measurements within device Septal-Lateral Annular Dimension not collected in Control group due to the presence of annuloplasty ring or replacement valve

45 Re-Inventing a Failed Surgical technique? The Importance of Annuloplasty Annuloplasty No annuloplasty 260 pts Overall freedom reop 90% (68% without ring) Alfieri O, et al. JTCVS 2001;122:674-81

46

47 Mitraclip Functional MR Results high risk EF - 55 % 8% 30 d 25% 1 yr DMR / FMR No controls Not random Left 2-4+ MR!

48 50 pts > 3+ MR CRT failed - 21 Age 70; euroscore 34; LVEDD 70mm; LVEDV 252 ml; LVEF 19% Franzen et al Eur J Heart Fail 2011; 13:569-76

49 Mitral regurgitation at baseline, discharge and 6 months Almost half had significant Residual MR! Franzen O et al. Eur J Heart Fail 2011;13:

50 Mitral Clip in FMR 17 % mortality! Franzen O et al. Eur J Heart Fail 2011;13:

51 Franzen O et al. Eur J Heart Fail 2011;13: LV Remodeling??

52 Optimal treatment of FMR Find MR! Fix MR! OMT, CRT, Clip (COAPT)

53 Optimal treatment for FMR GOOD SURGERY! Careful patient selection Beware the big LV and the bad RV! Repair - use complete rigid ring Replacement - selective RCT!

54 FMR is still a HEADACHE!!

I have financial relationships to disclose Honoraria from: Edwards

I have financial relationships to disclose Honoraria from: Edwards I have financial relationships to disclose Honoraria from: Edwards Mitral Valve Annuloplasty in Ischemic Mitral regurgitation Jean François Avierinos Hôpital Timone Marseille August 28, 2012 Ischemic MR

More information

Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan

Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan Degenerative MR is not Functional MR 2o - Functional MR : Ventricular Problem!!

More information

Concomitant Tricuspid Valve Repair :

Concomitant Tricuspid Valve Repair : Concomitant Tricuspid Valve Repair : When to perform while awaiting data?! Steven F Bolling, MD Professor of Cardiac Surgery University of Michigan Is FTR important? Decreased CO Fatigue, decreased exercise

More information

Understanding the guidelines for Interventions in MR. Ali AlMasood

Understanding the guidelines for Interventions in MR. Ali AlMasood Understanding the guidelines for Interventions in MR Ali AlMasood Mitral regurgitation The most diverse from all acquired valve diseases About 50% of patients with an LVEF 35 percent had moderate to severe

More information

Techniques for ischemic mitral valve disease: An Update. Stanford CV Surgery

Techniques for ischemic mitral valve disease: An Update. Stanford CV Surgery Techniques for ischemic mitral valve disease: An Update Conflict of Interest Disclosure Grant/ Research Support: NHLBI RO1 HL67025 Consulting Fees/Honoraria: Stanford PI PARTNER Trial, Edwards Lifesciences

More information

Prognostic Impact of FMR

Prognostic Impact of FMR Secondary Mitral Valve Regurgitation in Heart Failure, Age 60 Years From Medical Therapy to Surgical Repair to Transcatheter Intervention The Interventionalist s View Samin K Sharma, MD, FACC, FSCAI Director

More information

Transcatheter Mitral Valve Repair and Replacement: Where is the Latest Randomized Evidence Taking US Mitral-Fr, COAPT

Transcatheter Mitral Valve Repair and Replacement: Where is the Latest Randomized Evidence Taking US Mitral-Fr, COAPT Transcatheter Mitral Valve Repair and Replacement: Where is the Latest Randomized Evidence Taking US Mitral-Fr, COAPT and Saibal Kar, MD, FACC, FSCAI Professor of Medicine Director of Interventional Cardiac

More information

Functional Ischaemic Mitral Regurgitation: CABG + MV Replacement. Prakash P Punjabi. FRCS(Eng),FESC,MS,MCh,FCCP, Diplomate NBE

Functional Ischaemic Mitral Regurgitation: CABG + MV Replacement. Prakash P Punjabi. FRCS(Eng),FESC,MS,MCh,FCCP, Diplomate NBE Functional Ischaemic Mitral Regurgitation: CABG + MV Replacement Prakash P Punjabi FRCS(Eng),FESC,MS,MCh,FCCP, Diplomate NBE Consultant Cardiothoracic Surgeon Imperial College Healthcare NHS Trust Hammersmith

More information

Percutaneous technologies to correct TR : Myth or Reality? Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan

Percutaneous technologies to correct TR : Myth or Reality? Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan Percutaneous technologies to correct TR : Myth or Reality? Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan Disclosures Ownership Interest: Millipede and Pipeline TR is BAD Decreased

More information

Mitral valve treatment in advanced heart failure: Repair, Replacement, MitraClip. Nicola Buzzatti, MD San Raffaele Scientific Institute Milan, Italy

Mitral valve treatment in advanced heart failure: Repair, Replacement, MitraClip. Nicola Buzzatti, MD San Raffaele Scientific Institute Milan, Italy Mitral valve treatment in advanced heart failure: Repair, Replacement, MitraClip Nicola Buzzatti, MD San Raffaele Scientific Institute Milan, Italy Disclosures I have nothing to disclose FMR: a ventricular

More information

Surgical repair techniques for IMR: future percutaneous options?

Surgical repair techniques for IMR: future percutaneous options? Surgical repair techniques for IMR: can this teach us about future percutaneous options? Genk - Belgium Prof. Dr. R. Dion KULeu Disclosure slide Robert A. Dion I disclose the following financial relationships:

More information

Functional Mitral Regurgitation; therapeutic continuum overview. Michele Senni. Cardiologia 1 Scompenso e Trapianti di Cuore A.O. PAPA GIOVANNI XXIII

Functional Mitral Regurgitation; therapeutic continuum overview. Michele Senni. Cardiologia 1 Scompenso e Trapianti di Cuore A.O. PAPA GIOVANNI XXIII Functional Mitral Regurgitation; therapeutic continuum overview Michele Senni Cardiologia 1 Scompenso e Trapianti di Cuore A.O. PAPA GIOVANNI XXIII Functional Mitral Regurgitation FMR is not the result

More information

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,

More information

Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain

Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain Device Landscape 2010 PERCUTANEOUS TECHNIQUES Percutaneous indirect annuloplasty Percutaneous direct annuloplasty Edge to Edge ( E-Valve ) Non

More information

Surgical Approach To Functional MR: One Size Does Not Fit All

Surgical Approach To Functional MR: One Size Does Not Fit All 1 Surgical Approach To Functional MR: One Size Does Not Fit All Pavan Atluri, M.D Associate Professor of Surgery Director, Mechanical Circulatory Support and Heart Transplantation Director, Minimally Invasive

More information

Percutaneous Therapy for Mitral Regurgitation: Current and Future Options: Could we do better today?

Percutaneous Therapy for Mitral Regurgitation: Current and Future Options: Could we do better today? Percutaneous Therapy for Mitral Regurgitation: Current and Future Options: Could we do better today? Peter S. Fail, MD, FACC, FACP, FSCAI Director of the Cardiac Catheterization Laboratories and Interventional

More information

Percutaneous Mitral Valve Repair

Percutaneous Mitral Valve Repair Indiana Chapter of ACC November 15 th,2008 Percutaneous Mitral Valve Repair James B Hermiller, MD, FACC The Care Group, LLC St Vincent Hospital Indianapolis, IN Mechanisms of Mitral Regurgitation Mitral

More information

Ischemic Mitral Regurgitation

Ischemic Mitral Regurgitation Ischemic Mitral Regurgitation Jean-Louis J. Vanoverschelde, MD, PhD Université catholique de Louvain Brussels, Belgium Definition Ischemic mitral regurgitation is mitral regurgitation due to complications

More information

Catheter-based mitral valve repair MitraClip System

Catheter-based mitral valve repair MitraClip System Percutaneous Mitral Valve Repair: Results of the EVEREST II Trial William A. Gray MD Director of Endovascular Services Associate Professor of Clinical Medicine Columbia University Medical Center The Cardiovascular

More information

Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid

Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid Patient records 76 y.o. male Hypertension. Dyslipidemia. OPLD. Smoked in the past. Diabetes

More information

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Dr Χρήστος ΑΛΕΞΙΟΥ MD, PhD, FRCS(Glasgow), FRCS(CTh), CCST(UK) Consultant Cardiothoracic Surgeon Normal Mitral Valve Function Mitral Regurgitation

More information

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC MitraClip Therapy Saibal Kar, MD, FACC, FAHA, FSCAI Director of Interventional Cardiac Research Program Director, Interventional Cardiology Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA

More information

TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC

TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC NATURAL HISTORY OF MITRAL REGURGITATION Abdallah El Sabbagh et al. JIMG 2018;11:628-643 TREATMENT OPTIONS SURGERY REPAIR REPLACEMENT PERCUTANEOUS INTERVENTIONS

More information

Management of Tricuspid Regurgitation

Management of Tricuspid Regurgitation Management of Tricuspid Regurgitation Antonis A. Pitsis, FETCS, FESC Thessaloniki Heart Institute, St. Luke s Hospital, Thessaloniki, GREECE HEART FAILURE 2012 BELGRADE SERBIA Does Tricuspid Regurgitation

More information

Burden of Mitral Regurgitation (MR) in the US Why is This Important?

Burden of Mitral Regurgitation (MR) in the US Why is This Important? Secondary (Functional) Mitral Regurgitation as a Target for Heart Failure Therapy William T. Abraham, MD, FACP, FACC, FAHA, FESC, FRCP Professor of Medicine, Physiology, and Cell Biology Chair of Excellence

More information

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL DISCLOSURES I WILL BE DISCUSSING OFF-LABEL USAGE OF DEVICES RELATED TO TMVR OBJECTIVES

More information

Minimally invasive therapies for the mitral valve: How will you incorporate into your clinical practice? Guilherme F.

Minimally invasive therapies for the mitral valve: How will you incorporate into your clinical practice? Guilherme F. Minimally invasive therapies for the mitral valve: How will you incorporate into your clinical practice? Guilherme F. Attizzani, MD UH Harrington Heart and Vascular Institute Interventional Cardiologist/Structural

More information

The HRT Mitral Bridge Technology for Functional MR

The HRT Mitral Bridge Technology for Functional MR The HRT Mitral Bridge Technology for Functional MR Carlos E. Ruiz, MD, PhD, FACC, FESC, MSCAI Professor of Cardiology in Pediatrics and Medicine Director of Structural and Congenital Heart Disease Program

More information

Percutaneous Mitral Valve Repair

Percutaneous Mitral Valve Repair Percutaneous Mitral Valve Repair MitraClip: Procedure, Data, Patient Selection Chad Rammohan, MD FACC Director, Cardiac Cath Lab El Camino Hospital Mountain View, California Mitral Regurgitation MitraClip

More information

Chronic Primary Mitral Regurgitation

Chronic Primary Mitral Regurgitation Chronic Primary Mitral Regurgitation The Case For Early Surgical Intervention William K. Freeman, MD, FACC, FASE DISCLOSURES Relevant Financial Relationship(s) None Off Label Usage None Watchful Waiting......

More information

Τελικά επιδιόρθωση, αντικατάσταση ή clip στην ισχαιμική ανεπάρκεια Μιτροειδούς; ΒΛΑΣΗΣ ΝΙΝΙΟΣ MD MRCP ΚΛΙΝΙΚΗ ΑΓΙΟΣ ΛΟΥΚΑΣ

Τελικά επιδιόρθωση, αντικατάσταση ή clip στην ισχαιμική ανεπάρκεια Μιτροειδούς; ΒΛΑΣΗΣ ΝΙΝΙΟΣ MD MRCP ΚΛΙΝΙΚΗ ΑΓΙΟΣ ΛΟΥΚΑΣ Τελικά επιδιόρθωση, αντικατάσταση ή clip στην ισχαιμική ανεπάρκεια Μιτροειδούς; ΒΛΑΣΗΣ ΝΙΝΙΟΣ MD MRCP ΚΛΙΝΙΚΗ ΑΓΙΟΣ ΛΟΥΚΑΣ Carpentier MV Classification- Leaflet Mobility Normal Increased Decreased Mobility

More information

The Key Questions in Mitral Valve Interventions. Where Are We in 2018?

The Key Questions in Mitral Valve Interventions. Where Are We in 2018? The Key Questions in Mitral Valve Interventions Where Are We in 2018? Gilles D. DREYFUS, MD, FRCS, FESC Professor of Cardiothoracic Surgery 30 GIORNATE CARDIOLOGICHE TORINESI - OCT 2018 Are guidelines

More information

Mitral Regurgitation

Mitral Regurgitation Mitral Regurgitation Focus on Percutaneous Repair Steven J. Yakubov, MD FACC FSCAI System Chief, Structural Heart Diseaese, OhioHealth John H. McConnell Chair of Advanced Structural Heart Disease Medical

More information

Treatment options in ischaemic mitral regurgitation: surgery, clips, devices?

Treatment options in ischaemic mitral regurgitation: surgery, clips, devices? Treatment options in ischaemic mitral regurgitation: surgery, clips, devices? Francisco Leyva Conflicts of interest: FL has received advisory board fees from Medtronic Inc, Sorin, St Jude Medical and Abbot.

More information

Valvular Intervention

Valvular Intervention Valvular Intervention Outline Introduction Aortic Stenosis Mitral Regurgitation Conclusion Calcific Aortic Stenosis Deformed Eccentric Calcified Nodular Rigid HOSTILE TARGET difficult to displace prone

More information

Mitral Valve Disease, When to Intervene

Mitral Valve Disease, When to Intervene Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages

More information

Outline 9/17/2016. Advances in Percutaneous Mitral Valve Repair and Replacement. Scope of the Problem and Guidelines

Outline 9/17/2016. Advances in Percutaneous Mitral Valve Repair and Replacement. Scope of the Problem and Guidelines Advances in Percutaneous Mitral Valve Repair and Replacement Scott M Lilly MD PhD, Interventional Cardiology The Ohio State University Contemporary Multidisciplinary Cardiovascular Conference Orlando,

More information

Index. B B-type natriuretic peptide (BNP), 76

Index. B B-type natriuretic peptide (BNP), 76 Index A ACCESS-EU registry, 158 159 Acute kidney injury (AKI), 76, 88 Annular enlargement, RV, 177 178 Annuloplasty chordal cutting, 113 complete ring, 99 etiology-specific ring, 100 evolution, 98 flexible

More information

Repair or Replacement

Repair or Replacement Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division

More information

Valvular Guidelines: The Past, the Present, the Future

Valvular Guidelines: The Past, the Present, the Future Valvular Guidelines: The Past, the Present, the Future Robert O. Bonow, MD, MS Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern Memorial Hospital Editor-in-Chief,

More information

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for

More information

What is the Role of Surgical Repair in 2012

What is the Role of Surgical Repair in 2012 What is the Role of Surgical Repair in 2012 The Long-Term Results of Surgery Raphael Rosenhek Department of Cardiology Medical University of Vienna European Society of Cardiology 2012 Munich, August 27th

More information

Functional Mitral Regurgitation

Functional Mitral Regurgitation Club 35 - The best in heart valve disease - Functional Mitral Regurgitation Steven Droogmans, MD, PhD UZ Brussel, Jette, Belgium 08-12-2011 Euroecho & other Imaging Modalities 2011 No conflicts of interest

More information

The Mitral Revolution: Transcatheter Repair (and Replacement?) Going Mainstream

The Mitral Revolution: Transcatheter Repair (and Replacement?) Going Mainstream The Mitral Revolution: Transcatheter Repair (and Replacement?) Going Mainstream Matthew J. Price MD Director, Cardiac Catheterization Laboratory Scripps Clinic La Jolla, CA, USA price.matthew@scrippshealth.org

More information

Ischemic Mitral Valve Disease: Repair, Replace or Ignore?

Ischemic Mitral Valve Disease: Repair, Replace or Ignore? Ischemic Mitral Valve Disease: Repair, Replace or Ignore? Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil DISCLOSURE I have no financial relationship

More information

Percutaneous Repair for MR:

Percutaneous Repair for MR: Percutaneous Repair for MR: Follow-up and longer term outcomes Ted Feldman, M.D., FSCAI FACC FESC Evanston Hospital 16th ANGIOPLASTY SUMMIT TCT Asia Pacific 2011 April 27-29 th Seoul, Korea Ted Feldman

More information

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun Clinical Outcome of Tricuspid Regurgitation David Messika-Zeitoun I have financial relationships to disclose Consultant for: Edwards, Symetis and Valtech Tricuspid Regurgitation is a Common Finding Tricuspid

More information

Percutaneous Mitral Valve Intervention: QuantumCor Device

Percutaneous Mitral Valve Intervention: QuantumCor Device Percutaneous Mitral Valve Intervention: QuantumCor Device RICHARD R. HEUSER, MD, FACC, FACP, FESC Director Of Cardiology, St. Luke s Medical Center, Phoenix, Arizona Medical Director, Phoenix Heart Center,

More information

AATS Annual Meeting Seattle, WA Irving Kron, M.D. Professor and Chairman Department of Surgery University of Virginia Hospital Charlottesville,

AATS Annual Meeting Seattle, WA Irving Kron, M.D. Professor and Chairman Department of Surgery University of Virginia Hospital Charlottesville, AATS Annual Meeting Seattle, WA Irving Kron, M.D. Professor and Chairman Department of Surgery University of Virginia Hospital Charlottesville, Virginia AATS Ischemic MR Guideline Writing Group Roster

More information

Ischemic Mitral Regurgitation

Ischemic Mitral Regurgitation Ischemic Mitral Regurgitation 1 / 6 2 / 6 3 / 6 Ischemic Mitral Regurgitation Background Myocardial infarction (MI) can directly cause (IMR), which has been touted as an indicator of poor prognosis in

More information

TrattamentoTrans-catetere dell insufficienza mitralica. Francesco Bedogni. Istituto Clinico S. Ambrogio, Milano

TrattamentoTrans-catetere dell insufficienza mitralica. Francesco Bedogni. Istituto Clinico S. Ambrogio, Milano TrattamentoTrans-catetere dell insufficienza mitralica Francesco Bedogni Severe MR Leads to Increased Hospital Admissions and Lower Survival Rates Significantly higher hospital admissions experienced by

More information

Transcatheter Mitral Valve Repair: today and tomorrow Sponsored by Abbott. Chairperson: M. Haude Panellists: A. Al Nooryani, M.

Transcatheter Mitral Valve Repair: today and tomorrow Sponsored by Abbott. Chairperson: M. Haude Panellists: A. Al Nooryani, M. Transcatheter Mitral Valve Repair: today and tomorrow Sponsored by Abbott Chairperson: M. Haude Panellists: A. Al Nooryani, M. Al Otaiby Session objectives To learn about the clinical patient profile for

More information

Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical. The Houston Aortic Symposium February 23-25, 2017

Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical. The Houston Aortic Symposium February 23-25, 2017 James S. Gammie, MD Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical The Houston Aortic Symposium February 2-25, 2017 Disclosure Statement of Financial Interest Within

More information

Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Late secondary TR after left sided heart disease correction: is it predictibale and preventable Late secondary TR after left sided heart disease correction: is it predictibale and preventable Gilles D. Dreyfus Professor of Cardiothoracic surgery Nath J, et al. JACC 2004 PREDICT Incidence of secondary

More information

Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.

Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Decision process for Management of any valve Timing Feasibility

More information

Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation

Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Matthew L. Williams, MD, Mani A. Daneshmand, MD, James G. Jollis, MD, John

More information

CLIP ΜΙΤΡΟΕΙ ΟΥΣ: ΠΟΥ ΒΡΙΣΚΟΜΑΣΤΕ;

CLIP ΜΙΤΡΟΕΙ ΟΥΣ: ΠΟΥ ΒΡΙΣΚΟΜΑΣΤΕ; CLIP ΜΙΤΡΟΕΙ ΟΥΣ: ΠΟΥ ΒΡΙΣΚΟΜΑΣΤΕ; Επιµορφωτικά Σεµινάρια Ειδικευοµένων Καρδιολογίας 7 Απριλίου 2012 M Chrissoheris MD FACC THV Department HYGEIA Hospital Degenerative MR (DMR) Usually refers to an anatomic

More information

Introducing the COAPT Trial

Introducing the COAPT Trial physician INFORMATION Eligible patients Symptomatic functional mitral regurgitation 3+ Not suitable candidates for open mitral valve surgery NYHA functional class II, III, or ambulatory IV Introducing

More information

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi SC Cardiochirurgia U Universita degli Studi di Torino PORT-ACCESS TECNIQUE Reduce surgical trauma Minimize disruption of the chest wall

More information

Severe left ventricular dysfunction and valvular heart disease: should we operate?

Severe left ventricular dysfunction and valvular heart disease: should we operate? Severe left ventricular dysfunction and valvular heart disease: should we operate? Laurie SOULAT DUFOUR Hôpital Saint Antoine Service de cardiologie Pr A. COHEN JESFC 16 janvier 2016 Disclosure : No conflict

More information

Mitral Valve Disease. James Hermiller, MD, FACC, FSCAI St Vincent Heart Center Indianapolis, IN

Mitral Valve Disease. James Hermiller, MD, FACC, FSCAI St Vincent Heart Center Indianapolis, IN Mitral Valve Disease James Hermiller, MD, FACC, FSCAI St Vincent Heart Center Indianapolis, IN Disclosures Affiliation/Financial Relationship Consulting Fees/Honoraria Speaker Bureau Company Abbott, BSC,

More information

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines Christophe Tribouilloy Amiens, France I have no financial relationships to disclose related

More information

Valvular Heart Disease Transcatheter Valve Therapies. October 2016 Brian Whisenant MD

Valvular Heart Disease Transcatheter Valve Therapies. October 2016 Brian Whisenant MD Valvular Heart Disease Transcatheter Valve Therapies October 2016 Brian Whisenant MD Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement

More information

MitraClip: Why, How, and For Whom?

MitraClip: Why, How, and For Whom? MitraClip: Why, How, and For Whom? Robert O. Bonow, MD, MS Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern Memorial Hospital Editor-in-Chief, JAMA Cardiology

More information

What Degree of MR Deserves Surgical or Transcatheter Intervention, and How Should It Be Assessed?

What Degree of MR Deserves Surgical or Transcatheter Intervention, and How Should It Be Assessed? What Degree of MR Deserves Surgical or Transcatheter Intervention, and How Should It Be Assessed? Robert J. Siegel, M.D., FACC Nov. 14-15, 2017, Beverly Hills Director, Cardiac Non-Invasive Laboratory

More information

Use of MitraClip Beyond Everest Criteria

Use of MitraClip Beyond Everest Criteria Use of MitraClip Beyond Everest Criteria Takashi Matsumoto, MD Sendai Kousei Hospital Sendai, Japan No Disclosure of Financial Interest Introduction The efficacy and safety of the MitraClip therapy was

More information

What Is the Role of Mitral Repair in Heart Failure?

What Is the Role of Mitral Repair in Heart Failure? ASK THE EXPERTS What Is the Role of Mitral Repair in Heart Failure? Experts discuss treatment strategies for patients with mitral regurgitation progressing to heart failure. WITH WILLIAM WEIR, MD; STEPHEN

More information

Alec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France

Alec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France Future Percutaneous Therapies for Mitral Valve Disease (Mitraclip,percutaneous annuloplasty and transcatheter valve implantation) Will they reach the TAVI s success? Alec Vahanian,FESC, FRCP (Edin.) Bichat

More information

Surgical AF Ablation : Lesion Sets and Energy Sources. What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan

Surgical AF Ablation : Lesion Sets and Energy Sources. What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan Surgical AF Ablation : Lesion Sets and Energy Sources What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan Disclosures Consultant/Advisory Board: Abbott, Edwards Lifesciences

More information

Transcatheter Mitral Valve for fmr: The Era of Too Many Options

Transcatheter Mitral Valve for fmr: The Era of Too Many Options Transcatheter Mitral Valve for fmr: The Era of Too Many Options Isaac George, M.D. Surgical Director, Structural Heart & Valve Center Assistant Professor of Surgery Columbia University Medical Center Disclosure

More information

MEDICAL POLICY SUBJECT: SURGICAL VENTRICULAR RESTORATION

MEDICAL POLICY SUBJECT: SURGICAL VENTRICULAR RESTORATION MEDICAL POLICY SUBJECT: SURGICAL VENTRICULAR PAGE: 1 OF: 6 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including

More information

Mitral club: From clinical practice to guidelines: the world upside down

Mitral club: From clinical practice to guidelines: the world upside down Mitral club: From clinical practice to guidelines: the world upside down Christina Chrysohoou Heart Failure Unit 1rst Cardiology Clinic, University of Athens Hippokratio Hospital, Greece Stages of Chronic

More information

Secondary Mitral Regurgitation: When Should We Intervene?

Secondary Mitral Regurgitation: When Should We Intervene? /19/17 Secondary Mitral Regurgitation: When Should We Intervene? Robert O. Bonow, MD, MS, MACC Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern Memorial Hospital

More information

Imaging to select patients for Transcatheter TV

Imaging to select patients for Transcatheter TV Imaging to select patients for Transcatheter TV Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands San Diego, february 2018 Research grants: Medtronic, Biotronik, Boston Scientific,

More information

Mitral Valve Repair for Functional Mitral Regurgitation in End-Stage Dilated Cardiomyopathy Role of the Edge-to-Edge Technique

Mitral Valve Repair for Functional Mitral Regurgitation in End-Stage Dilated Cardiomyopathy Role of the Edge-to-Edge Technique Mitral Valve Repair for Functional Mitral Regurgitation in End-Stage Dilated Cardiomyopathy Role of the Edge-to-Edge Technique Michele De Bonis, MD; Elisabetta Lapenna, MD; Giovanni La Canna, MD; Eleonora

More information

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015 Imaging MV Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015 MV/MR: information needed on.. 1. MV anatomy 2. MR etiology - primary vs secondary 3. MR severity quantification

More information

Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens

Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens MITRAL REGURGITATION IN PATIENT WITH SEVERE AORTIC VALVE STENOSIS Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens I HAVE NOTHING TO DECLARE Management

More information

Management of Secondary MR : Insights from CTSN Ischemic MR trial; COAPT and MITRA-FR:

Management of Secondary MR : Insights from CTSN Ischemic MR trial; COAPT and MITRA-FR: Management of Secondary MR : Insights from CTSN Ischemic MR trial; COAPT and MITRA-FR: Saibal Kar, MD, FACC, FSCAI Professor of Medicine Director of Interventional Cardiac Research Smidt Heart Institute,

More information

Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation

Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation Accepted Manuscript Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation Wobbe Bouma, MD PhD, Robert C. Gorman, MD PII: S0022-5223(18)32805-8

More information

Imaging in dilated cardiomyopathy : factors associated with a poor outcome

Imaging in dilated cardiomyopathy : factors associated with a poor outcome Imaging in dilated cardiomyopathy : factors associated with a poor outcome Johan De Sutter, MD, PhD, FESC AZ Maria Middelares Gent and University Gent - Belgium Dilated cardiomyopathy Cardiomyopathy with

More information

Management of HOCM: Non-Surgical Options

Management of HOCM: Non-Surgical Options Management of HOCM: Non-Surgical Options Howard C. Herrmann, MD, FACC, MSCAI John Bryfogle Professor of Cardiovascular Medicine and Surgery Health System Director for Interventional Cardiology Director,

More information

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? Prof. Patrizio LANCELLOTTI, MD, PhD GIGA Cardiovascular Sciences, Heart Valve Clinic, University of Liège, CHU

More information

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?

More information

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Disclosures: GE stock, Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Athena Poppas, MD FACC Past ACC Scientific Sessions Chair, ACC Board

More information

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,

More information

(Ann Thorac Surg 2008;85:845 53)

(Ann Thorac Surg 2008;85:845 53) I Made Adi Parmana The utility of intraoperative TEE has become increasingly more evident as anesthesiologists, cardiologists, and surgeons continue to appreciate its potential application as an invaluable

More information

What echo measurements are key prior to MitraClip?

What echo measurements are key prior to MitraClip? APHP CHU Bichat - Claude Bernard What echo measurements are key prior to MitraClip? Eric Brochet,MD Cardiology Department Hopital Bichat Paris France No disclosure Conflict of interest Case 69 y.o man

More information

Percutaneous Tricuspid Valve Therapies: The Next Frontier? Is the Tricuspid Valve Relevant? Data and Guidelines for TV Interventions

Percutaneous Tricuspid Valve Therapies: The Next Frontier? Is the Tricuspid Valve Relevant? Data and Guidelines for TV Interventions Percutaneous Tricuspid Valve Therapies: The Next Frontier? Scott M Lilly, MD PhD The Ohio State University Structural Heart Disease Course May 19 th, 2017 Outline Is the Tricuspid Valve Relevant? Data

More information

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection

More information

What are the indications for Tricuspid valve repair during LVAD Implant RANJIT JOHN, MD UNIVERSITY OF MINNESOTA

What are the indications for Tricuspid valve repair during LVAD Implant RANJIT JOHN, MD UNIVERSITY OF MINNESOTA What are the indications for Tricuspid valve repair during LVAD Implant RANJIT JOHN, MD UNIVERSITY OF MINNESOTA Contraindications for LVAD Lack of social support system Nonreversible end organ failure

More information

Ischemic mitral regurgitation (IMR) is an insufficiency of

Ischemic mitral regurgitation (IMR) is an insufficiency of Repair Techniques for Ischemic Mitral Regurgitation Damien J. LaPar, MD, MSc, and Irving L. Kron, MD Ischemic mitral regurgitation (IMR) is an insufficiency of the mitral valve (MV) secondary to myocardial

More information

Management of High-Risk CAD : Surgeons Perspective

Management of High-Risk CAD : Surgeons Perspective Management of High-Risk CAD : Surgeons Perspective Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan Conflict : Cardiac Surgeon! High Risk CABG 77 year old with prior large anterior

More information

Status Of The MitraClip: Trials (EVEREST II & COAPT) & FDA

Status Of The MitraClip: Trials (EVEREST II & COAPT) & FDA Status Of The MitraClip: Trials (EVEREST II & COAPT) & FDA Ted Feldman, M.D., FSCAI FACC FESC Evanston Hospital SCAI Fall Fellows Course Las Vegas, Nevada December 8 11 th, 2013 Ted Feldman MD, FACC, FESC,

More information

Current status: Percutaneous mitral valve therapy

Current status: Percutaneous mitral valve therapy Current status: Percutaneous mitral valve therapy Ted Feldman, M.D., FSCAI FACC FESC Evanston Hospital ESC Stockholm 2010 Disclosures Research Grants Abbott, Edwards Consultant Abbott, Edwards 2 Percutaneous

More information

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT)

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT) UNIVERSITY OF PADUA, SCHOOL OF MEDICINE Department of Cardiac,Thoracic and Vascular Sciences Padua, Italy MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT) Luigi P. Badano**, MD, PhD, FESC,

More information

GDMT for percutaneous mitral valve repair

GDMT for percutaneous mitral valve repair GDMT for percutaneous mitral valve repair Ted Feldman, M.D., MSCAI FACC FESC Evanston Hospital The 11th Annual Innovations & Trends in Cardiovascular Care New Brunswick, NJ October 18 th 2014 Ted Feldman

More information

Treatment for functional mitral regurgitation

Treatment for functional mitral regurgitation Transcatheter Leaflet Repair for Functional MR What will randomized trials mean for the future of mitral intervention? BY TED FELDMAN, MD, FESC, FACC, MSCAI; PAUL SORAJJA, MD, FACC, FSCAI; PAUL GRAYBURN,

More information

Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων. Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος

Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων. Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος MV anatomy Otto C. NEJM 2001 Leaflets anatomy 2% of population Etiology Terminology

More information

Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients?

Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients? Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients? David H. Adams, MD Cardiac Surgeon-in-Chief Mount Sinai Health System Marie Josée and Henry R. Kravis Professor and

More information

SURGICAL AND TRANSCATHETER MITRAL VALVE REPLACEMENT VS. REPAIR: COMPETITION OR SYNERGY

SURGICAL AND TRANSCATHETER MITRAL VALVE REPLACEMENT VS. REPAIR: COMPETITION OR SYNERGY SURGICAL AND TRANSCATHETER MITRAL VALVE REPLACEMENT VS. REPAIR: COMPETITION OR SYNERGY Michael J. Reardon, M.D. Professor of Cardiothoracic Surgery Allison Family Distinguish Chair of Cardiovascular Research

More information